About Us
Diaceutics mission is to build formal bridges – frameworks - for collaboration and partnering between key pharmaceutical and diagnostics players in pursuit of shared personalized medicine goals.
Formed in 2003, Diaceutics is a novel business consultancy, borne of joint strategic and operational experience in both the pharmaceutical and diagnostic industries. Diaceutics' primary role has been to provide the necessary analytical content and decision frameworks upon which drug development teams can learn to build the operational processes of drug and test co-development in the personalized medicine space.
Our Focus: Evidence-Based Frameworks and Personalized Medicine
Utilizing its accumulated personalized medicine knowledge, specialist team, and fit-for-purpose decision tools, Diaceutics helps to remove internal roadblocks to co-development and infuse the capability to seamlessly integrate a diagnostic partner into the development process in order to optimize market strategy and launch capability.
Reinforcing and building on the core competencies of the drug development process, Diaceutics has developed a number of services and IT enabled programs designed to mirror the pharmaceutical development and lifecycle model and to aid in the integration of personalized medicineconcepts and to provide sound, reasoned, analytical metrics on which development, commercialization, market strategy, partnering, launch and return on investment are optimized.
Formed in 2003, Diaceutics is a novel business consultancy, borne of joint strategic and operational experience in both the pharmaceutical and diagnostic industries. Diaceutics' primary role has been to provide the necessary analytical content and decision frameworks upon which drug development teams can learn to build the operational processes of drug and test co-development in the personalized medicine space.
Our Focus: Evidence-Based Frameworks and Personalized Medicine
Utilizing its accumulated personalized medicine knowledge, specialist team, and fit-for-purpose decision tools, Diaceutics helps to remove internal roadblocks to co-development and infuse the capability to seamlessly integrate a diagnostic partner into the development process in order to optimize market strategy and launch capability.
Reinforcing and building on the core competencies of the drug development process, Diaceutics has developed a number of services and IT enabled programs designed to mirror the pharmaceutical development and lifecycle model and to aid in the integration of personalized medicineconcepts and to provide sound, reasoned, analytical metrics on which development, commercialization, market strategy, partnering, launch and return on investment are optimized.